Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study-Reference-Cited by-同舟云学术

Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study

Published:2019-09 Issue: Volume:27 Page:34-38
ISSN:1572-1000
Container-title:Photodiagnosis and Photodynamic Therapy
language:en
Short-container-title:Photodiagnosis and Photodynamic Therapy

Author:

Gracia-Cazaña Tamara,Malinis Ana Julia García,Almagro-Sánchez Manuel,Linares Dolores Planas,Gilaberte Yolanda

Funder

Government of Aragon

Publisher

Elsevier BV

Subject

Pharmacology (medical),Dermatology,Oncology,Biophysics

Reference19 articles.

1. The actinic keratosis. A perspective and update;Schwartz;Dermatol. Surg.,1997

2. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification;Röwert-Huber;Br. J. Dermatol.,2007

3. A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications;Braakhuis;Cancer Res.,2003

4. Development of a treatment algorithm for actinic keratoses: a European Consensus;Stockfleth;Eur. J. Dermatol.,2019

5. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis;Genovese;Dermatol. Ther.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?;Dermatology Practical & Conceptual;2023-10-31

2. Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches;Journal of Skin Cancer;2021-06-19